Search Results - "Anh, T. Le"

Refine Results
  1. 1

    TRKing down an old oncogene in a new era of targeted therapy by Vaishnavi, Aria, Le, Anh T, Doebele, Robert C

    Published in Cancer discovery (01-01-2015)
    “…The use of high-throughput next-generation sequencing techniques in multiple tumor types during the last few years has identified NTRK1, 2, and 3 gene…”
    Get more information
    Journal Article
  2. 2

    Lignin degradation by microorganisms: A review by Atiwesh, Ghada, Parrish, Christopher C., Banoub, Joseph, Le, Tuyet‐Anh T.

    Published in Biotechnology progress (01-03-2022)
    “…Lignin is an abundant plant‐based biopolymer that has found applications in a variety of industries from construction to bioethanol production. This…”
    Get full text
    Journal Article
  3. 3

    Environmental impact of bioplastic use: A review by Atiwesh, Ghada, Mikhael, Abanoub, Parrish, Christopher C., Banoub, Joseph, Le, Tuyet-Anh T.

    Published in Heliyon (01-09-2021)
    “…Throughout their lifecycle, petroleum-based plastics are associated with many environmental problems, including greenhouse gas emissions, persistence in marine…”
    Get full text
    Journal Article
  4. 4

    Policy Responses to the COVID-19 Pandemic in Vietnam by Le, Tuyet-Anh T, Vodden, Kelly, Wu, Jianghua, Atiwesh, Ghada

    “…The COVID-19 pandemic has become one of the most serious health crises in human history, spreading rapidly across the globe from January 2020 to the present…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples by Davies, Kurtis D, Le, Anh T, Sheren, Jamie, Nijmeh, Hala, Gowan, Katherine, Jones, Kenneth L, Varella-Garcia, Marileila, Aisner, Dara L, Doebele, Robert C

    Published in Journal of thoracic oncology (01-10-2018)
    “…ROS1 gene fusions are a well-characterized class of oncogenic driver found in approximately 1% to 2% of NSCLC patients. ROS1-directed therapy in these patients…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes by Estrada-Bernal, Adriana, Le, Anh T, Doak, Andrea E, Tirunagaru, Vijaya G, Silva, Shevan, Bull, Matthew R, Smaill, Jeff B, Patterson, Adam V, Kim, Chul, Liu, Stephen V, Doebele, Robert C

    Published in Clinical cancer research (01-03-2021)
    “…Approved therapies for exon 20, mutations, and fusions are currently lacking for non-small cell lung cancer and other cancers. Tarloxotinib is a prodrug that…”
    Get full text
    Journal Article
  11. 11

    An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer by Dziadziuszko, Rafal, Le, Anh T, Wrona, Anna, Jassem, Jacek, Camidge, D Ross, Varella-Garcia, Marileila, Aisner, Dara L, Doebele, Robert C

    Published in Journal of thoracic oncology (01-08-2016)
    “…Patients with non-small cell lung cancer (NSCLC) harboring ROS proto-oncogene 1, receptor tyrosine kinase gene (ROS1) chromosomal rearrangements benefit from…”
    Get more information
    Journal Article
  12. 12

    Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer by Davies, Kurtis D, Mahale, Sakshi, Astling, David P, Aisner, Dara L, Le, Anh T, Hinz, Trista K, Vaishnavi, Aria, Bunn, Jr, Paul A, Heasley, Lynn E, Tan, Aik-Choon, Camidge, D Ross, Varella-Garcia, Marileila, Doebele, Robert C

    Published in PloS one (13-12-2013)
    “…The targeting of oncogenic 'driver' kinases with small molecule inhibitors has proven to be a highly effective therapeutic strategy in selected non-small cell…”
    Get full text
    Journal Article
  13. 13

    Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling by Nelson-Taylor, Sarah K, Le, Anh T, Yoo, Minjae, Schubert, Laura, Mishall, Katie M, Doak, Andrea, Varella-Garcia, Marileila, Tan, Aik-Choon, Doebele, Robert C

    Published in Molecular cancer therapeutics (01-08-2017)
    “…Oncogenic rearrangements in are present in 1%-2% of lung adenocarcinoma patients. Ponatinib is a multi-kinase inhibitor with low-nanomolar potency against the…”
    Get full text
    Journal Article
  14. 14

    Household-Contact Investigation for Detection of Tuberculosis in Vietnam by Fox, Greg J, Nhung, Nguyen V, Sy, Dinh N, Hoa, Nghiem L.P, Anh, Le T.N, Anh, Nguyen T, Hoa, Nguyen B, Dung, Nguyen H, Buu, Tran N, Loi, Nguyen T, Nhung, Le T, Hung, Nguyen V, Lieu, Phan T, Cuong, Nguyen K, Cuong, Pham D, Bestrashniy, Jessica, Britton, Warwick J, Marks, Guy B

    Published in The New England journal of medicine (18-01-2018)
    “…Tuberculosis continues to be a global health challenge. In this report, active case finding was more than twice as likely as standard passive case finding to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Genotypic and Phenotypic Diversity of Endemic Golden Camellias Collected from the North of Vietnam by Van‐Anh Le, T., Mai Nga, T. P., Nhi Nguyen, P., Kieu‐Oanh Nguyen, T.

    Published in Chemistry & biodiversity (01-01-2023)
    “…Golden Camellias have recently been used as a food, cosmetic, and traditional medicine in China and Vietnam. Forty‐two species have natural distribution in…”
    Get full text
    Journal Article
  17. 17

    Investigating the determinants and process of destination management system (DMS) implementation by Le, Anh T. P, Kunasekaran, Puvaneswaran, Rasoolimanesh, S. Mostafa, AriRagavan, Neethiahnanthan, Thomas, Toney K

    “…PurposeThis study aims to propose a comprehensive model to help understand factors influencing the intention to participate in a destination management system…”
    Get full text
    Journal Article
  18. 18

    Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes by Harper, Angelica R., Le, Anh T., Mather, Timothy, Burgett, Anthony, Berry, William, Summers, Jody A.

    Published in Bioorganic & medicinal chemistry (01-12-2018)
    “…[Display omitted] The retinaldehyde dehydrogenase (RALDH) enzymes, RALDH1, RALDH2, and RALDH3, catalyze the irreversible oxidation of retinaldehyde to…”
    Get full text
    Journal Article
  19. 19

    Payments for ecosystem services programs: A global review of contributions towards sustainability by Le, Tuyet-Anh T., Vodden, Kelly, Wu, Jianghua, Bullock, Ryan, Sabau, Gabriela

    Published in Heliyon (15-01-2024)
    “…Payments for ecosystem services programs (PESPs) are increasingly being adopted globally to enhance sustainability outcomes. There are also hundreds of studies…”
    Get full text
    Journal Article
  20. 20

    High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity by Pingali, Pavani, Wu, Y. Jeffrey, Boothello, Rio, Sharon, Chetna, Li, Howard, Sistla, Srinivas, Sankaranarayanan, Nehru Viji, Desai, Umesh R., Le, Anh T., Doebele, Robert C., Muldoon, Leslie L., Patel, Bhaumik B., Neuwelt, Alexander

    Published in Neoplasia (New York, N.Y.) (01-03-2021)
    “…High-dose acetaminophen (AAP) with delayed rescue using n-acetylcysteine (NAC), the FDA-approved antidote to AAP overdose, has demonstrated promising antitumor…”
    Get full text
    Journal Article